
Topic
Liver Cancer
Podcasts
Vascular & IR # 673Sep 8, 2026Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study

The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can tolerate, where to deliver it, and when to safely push the dose. In this episode of the BackTable Podcast, Drs. Tyler Sandow and Ryan Hickey join host Dr. Kavi Krishnasamy to explore strategies for using Y90 in hepatocellular carcinoma and liver metastases. They combine real-world data from a study of nearly 1,000 patients with insights into methodology and the many variables that influence these procedures.
90m
Tumor Board # 59May 12, 2026Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.
25m
Tumor Board # 58May 5, 2026Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options

When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options are available for second-line therapy? In this episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi explore the uncertain landscape of second-line treatment after first-line immunotherapy, such as atezolizumab and bevacizumab or the STRIDE regimen, including practical considerations for choosing which second-line therapy to use.
26m
Vascular & IR # 640May 1, 2026Hepatic Arteriography & C-Arm CT-Guided Liver Ablation

When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In this episode of the BackTable Podcast, Netherlands interventional oncologist Dr. Maarten (M.L.J.) Smits shares a step-by-step walkthrough of the new hepatic arteriography and C-arm CT–guided ablation (HepACAGA) technique, punctuated with a real-world case series at the end. Find out how intra-arterial contrast, cone-beam CT, and 3D needle guidance can improve tumor conspicuity, targeting accuracy, and ablation margin assessment within a single angiography suite.
86m
Vascular & IR # 639Apr 30, 2026Advancements in Ablation Techniques for Liver Tumors

Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence? Host Dr. Kavi Krishnasamy sits down with interventional radiologists Dr. Christopher Malone (WashU, St. Louis) and Dr. Kirema Garcia-Reyes (Mount Sinai, NYC) at our 2026 HCC Creator Weekend™ in-studio in New Orleans to discuss modern liver ablation strategies for HCC and metastatic disease. The conversation centers on challenging real-world cases, combining multidisciplinary tumor board insights with hands-on experience using ablation confirmation software, radiofrequency, cryo, and microwave ablation.
29m
Tumor Board # 57Apr 28, 2026First-Line Therapy for Advanced Hepatocellular Carcinoma: Decisions in the Real World

Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In this inaugural episode of the BackTable 2026 HCC Creator Weekend™ , medical oncologists Dr. John Rahi, Dr. Craig Lockhart, and Dr. Lingling Du review the evolution of first-line systemic therapy for hepatocellular carcinoma (HCC), highlighting immune checkpoint inhibitors as a major change from the TKI era.
29m
Vascular & IR # 632Apr 8, 2026Career Choices That Work & Those That Don't Work

You may know him as the godfather of Y90, but you might not know what it took for Dr. Riad Salem to earn that title. Curiosity, ambition, critical thinking. High highs and devastating losses. This episode offers an inside look at how intellectual curiosity and patient focus fuel innovation in interventional radiology, featuring the man himself and hosts Dr. Tyler Sandow and Dr. Juan Gimenez in-studio in New Orleans.
44m
Vascular & IR # 577Sep 30, 2025Microwave Ablation for Liver Tumors: Techniques & Outcomes

Is microwave ablation only for simple liver tumors, or can it be a versatile ‘Swiss Army knife’ for a wide range of complex cases? In this episode, Dr. Driss Raissi of the University of Kentucky returns to BackTable to join host Dr. Chris Beck for a deep dive into advanced and unconventional microwave ablation techniques. They cover strategies for tackling a wide range of cases, from desmoid tumors to enterocutaneous fistulas.
51m
Industry # 91May 30, 2025Winding Down Neuwave: Impact on Interventional Radiology

It’s official — NeuWave is exiting the market. In this episode, Dr. Christopher Beck hosts a conversation with Dr. Josh Kuban, an interventional radiologist at MD Anderson Cancer Center, to discuss the impact that NeuWave's microwave tumor ablation technology has had on the field of interventional oncology and the recent announcement of its discontinuation, scheduled for March 2026.
29m
Vascular & IR # 548May 30, 2025Winding Down Neuwave: Impact on Interventional Radiology

It’s official — NeuWave is exiting the market. In this episode, Dr. Christopher Beck hosts a conversation with Dr. Josh Kuban, an interventional radiologist at MD Anderson Cancer Center, to discuss the impact that NeuWave's microwave tumor ablation technology has had on the field of interventional oncology and the recent announcement of its discontinuation, scheduled for March 2026.
30m
Vascular & IR # 524Mar 11, 2025Collaborative Oncology: Surgeon’s Perspective & Role in Locoregional Therapy

Medical, surgical, radiation, and interventional oncology all play vital roles in delivering care to patients battling liver cancer. How do we optimize outcomes when so many specialties have something to offer the same patient? The answer is collaborative oncology. Dr. Robert Martin (Director of Surgical Oncology, University of Louisville) and pioneer in liver-directed therapies, joins host Dr. Sabeen Dhand to discuss a collaborative approach to oncology and recent advances in locoregional therapy.
40m
Vascular & IR # 495Nov 12, 2024Microwave Ablation Techniques: Dr. Ed Kim's Approach

Is your microwave ablation technique up to date? Dr. Ed Kim sits down with guest-host Dr. Kavi Krishnasamy to explore cutting-edge techniques in tumor ablation, with a focus on hepatocellular carcinoma (HCC) treatment with microwave. Dr. Ed Kim is the Director of Interventional Oncology and Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Mount Sinai Medical Center.
58m
Vascular & IR # 494Nov 8, 2024Multidisciplinary Cancer Care: Lynn's Chemoembolization and More

How do interventional oncologists fit into the bigger picture of multidisciplinary cancer care? Today we hear the patient’s perspective from Lynn Lazzaro, a liver cancer survivor who underwent multiple interventional oncology procedures prior to liver resection and eventual transplant. Lynn sits down with host Dr. Eric Keller to discuss her journey from initial diagnosis to present day.
29m
Vascular & IR # 485Oct 4, 2024Mastering Microwave Ablation in HCC Treatment

Are you up-to-date on microwave ablation for hepatocellular carcinoma (HCC) treatment? Dr. Zachary Berman and host Dr. Michael Barraza discuss this treatment modality. They cover the spectrum of pre-procedure imaging and planning, procedure steps, and tips for navigating difficult cases. Dr. Berman is a hepatobiliary interventional oncologist and Associate Clinical Professor of Radiology at UC San Diego School of Medicine.
43m
Vascular & IR # 378Oct 25, 2023Setting the Benchmark: Ablation Confirmation Software for Tumors

In this episode, Dr. Constantinos (Costi) Sofocleous, Dr. Bruno Odisio, and Dr. William Rilling discuss the history of percutaneous liver tumor ablation, takeaways from past and present clinical studies, and the contemporary role of ablation margin confirmation software for optimizing treatment outcomes.
48m
Industry # 47Mar 8, 2023Robotics in Interventional Oncology

In this episode, host Aaron Fritts interviews engineer Lucien Blondel, co-founder and CTO of Quantum Surgical. We discuss robotic applications for interventional oncology procedures and the Epione robot’s impacts on workflow and accuracy.
43m
Vascular & IR # 299Mar 8, 2023Robotics in Interventional Oncology

In this episode, host Aaron Fritts interviews engineer Lucien Blondel, co-founder and CTO of Quantum Surgical. We discuss robotic applications for interventional oncology procedures and the Epione robot’s impacts on workflow and accuracy.
44m
Vascular & IR # 158Oct 3, 2021Microwave Ablation for Liver Lesions

Dr. Christopher Beck talks with Dr. Driss Raissi about his approach to Microwave Ablation of Liver Lesions, including workup, technique, and tips and tricks for a successful ablation treatment.
60m